Related Experiment Video
Updated: May 6, 2026

09:12
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
9.6K
Survival does not differ by annual center transplant volume-A Pediatric Heart Transplant Society Registry study
A Marion Ybarra1, Alicia M Kamsheh1, Matthew J O'Connor2
1Department of Pediatrics, Division of Pediatric Cardiology, Washington University in St. Louis, St. Louis, Missouri, USA.
Pediatric Transplantation
|March 4, 2024
Summary
Pediatric heart transplant center volume does not impact patient survival or graft loss, even for high-risk congenital heart disease (CHD) patients. Outcomes were similar across centers of all sizes in this large registry study.
Area of Science:
- Pediatric Cardiology
- Transplantation Medicine
- Health Services Research
Background:
- Conflicting data exist on the relationship between pediatric heart transplant center volume and patient outcomes.
- Previous studies may not have adequately addressed case mix differences, particularly in high-risk congenital heart disease (CHD) populations.
- Understanding the impact of center volume on outcomes is crucial for optimizing pediatric heart transplantation.
Purpose of the Study:
- To evaluate the association between pediatric heart transplant center volume and patient outcomes.
- To investigate whether case mix influences the relationship between center volume and outcomes.
Main Methods:
- Retrospective cohort study utilizing the Pediatric Heart Transplant Society (PHTS) Registry (2009-2018).
- Centers categorized into five groups based on average annual heart transplant volume.
- Primary outcome: time to death or graft loss, analyzed using Kaplan-Meier methods.
Main Results:
- Analysis of 4583 pediatric heart transplants across 55 centers revealed no significant difference in survival or graft loss based on center volume.
- This finding held true for the overall cohort, as well as for patients with congenital heart disease (CHD) and cardiomyopathy.
- No volume-outcome relationship was observed for patients undergoing transplantation post-Norwood, Glenn, or Fontan procedures, except for a significant difference in positive crossmatch cases without a clear volume pattern.
Conclusions:
- Pediatric heart transplant outcomes are comparable across centers of all sizes, including for high-risk CHD patients.
- Further research is required to explore patient-specific risk factors and their variation among centers of different volumes.
Related Concept Videos
Bone Marrow Sampling and Transplants
3.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
850
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
850

